Conditions: Persistent or Permanent Non-valvular Atrial Fibrillation
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 128
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the safety and tolerability of AZD0837 in patients with atrial fibrillation who are unable or unwilling to take vitamin K antagonist therapy for up to 3 months.

Detailed description:

Arms:

Interventions: intervention 1: AZD0837 intervention 2: Aspirin
Intervention descriptions: intervention 1: ER formulation intervention 2: Oral form

Protocol document: